This is the authors' abstract. We don't add key points for this paper.
Male patients with spinal cord involvement at disease onset have a lower risk of relapsing disease and longer latency to first relapse. Steroid treatment for at least 1 month at first attack was also associated with a monophasic disease course. MOG-antibody negative seroconversion was associated with a lower risk of relapse and may help inform treatment decisions and duration.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Huda et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: